JP2008061669A - Multi-chamber container - Google Patents

Multi-chamber container Download PDF

Info

Publication number
JP2008061669A
JP2008061669A JP2006239716A JP2006239716A JP2008061669A JP 2008061669 A JP2008061669 A JP 2008061669A JP 2006239716 A JP2006239716 A JP 2006239716A JP 2006239716 A JP2006239716 A JP 2006239716A JP 2008061669 A JP2008061669 A JP 2008061669A
Authority
JP
Japan
Prior art keywords
discharge port
drug
drug bag
internal cavity
shape
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006239716A
Other languages
Japanese (ja)
Inventor
Shoichi Kitagawa
彰一 北川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP2006239716A priority Critical patent/JP2008061669A/en
Publication of JP2008061669A publication Critical patent/JP2008061669A/en
Pending legal-status Critical Current

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To provide a multi-chamber container which reliably mixes medicaments and discharge the mixed medicament. <P>SOLUTION: A cylindrical insert 30 made of a rubber is press-fitted in and is welded to the inner circumference of a discharge outlet 12 inside the discharge outlet 12. The insert 30 is formed into a cylindrical shape with an elastomer rubber having an adequate thickness, and the central part is displaced due to the elasticity between a first state in which the central part is curved and protruded greatly into a hollow side of a medicament bag 10 and is substantially closed and a second state in which the central part is protruded to the side of a rubber stopper 20 and is opened. When the welded part between the separated chambers is not opened, the insert remains in the first shape, and the discharge of the medicament is prevented since the liquid flow is not initiated substantially even if the rubber stopper is punctured. The insert is transformed from the first shape into the second shape by liquid pressure at the time of the opening of the welded part. Since an opening part is formed on the insert 30, the medicament is discharged through the opening part. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

この発明は、内部空洞がシール部によって分離されることにより、それぞれが別個に薬液を封止収納する複数の隔室を形成した薬剤バッグより成り、夫々の隔室からの薬液が混合された後に排出口より排出させるようにした複室容器及び輸液方法に関する。   This invention consists of a drug bag in which the internal cavity is separated by a seal portion, each of which forms a plurality of compartments for separately storing and storing a chemical solution, and after the chemical solution from each compartment is mixed The present invention relates to a multi-chamber container which is discharged from a discharge port and an infusion method.

輸液用複室容器においては、軟弱フィルムを素材とする薬剤バッグの対向面を相対的に低温にて溶着して成る弱シール部によってそれぞれ異なった薬液を収容する複数の隔室に分離したものがある。薬剤バッグの外周には、プラスチック成型品としての排出口が設けられ、排出口は筒状に形成され、その内部空洞は一端側で一方の隔室に開口しているが、他端にはゴム栓が設けられている。患者への薬液の投与に先立って薬剤バッグを外側から加圧することによって弱シール部が剥離開通せしめられ、薬剤バッグの内部空洞は一室となるため2種類の薬液は混合され、輸液セットの穿刺針によりゴム栓を穿刺し、薬剤バッグよりの薬液の投与が可能となる。従って、この種の医療用混合型複室容器においては薬液の投与に先立って弱シール部の剥離開通により両液を混合せしめる作業は必須であり、他方、弱シール部の開通を行わないままで排出口におけるゴム栓の穿刺を行うと、排出口側の隔室における薬液のみが投与されてしまうという誤操作の可能性があった。この問題点に対処する従来技術として、薬剤バッグの内部空洞を二つの隔室に分離する第1の弱シール部に加えて、排出口の直前に第2の弱シール部を設け、第1の弱シール部の開通に要する圧力に対して第2の第2の弱シール部を同等若しくはそれ以上とすることにより、第1の弱シール部次いで第2の弱シール部の順序で開通されるようにし、これにより薬液の混合後に排出が行われるようにしたものが提案されている(特許文献1参照)。
特開平9−327498号公報
In a multi-chamber container for infusion, the container separated by a weak seal part formed by welding the opposite surfaces of a drug bag made of a soft film at a relatively low temperature is divided into a plurality of compartments each containing different drug solutions. is there. A discharge port as a plastic molded product is provided on the outer periphery of the drug bag, the discharge port is formed in a cylindrical shape, and the internal cavity is open to one compartment on one end side, but the other end is a rubber A stopper is provided. Prior to administration of the drug solution to the patient, the weak seal is peeled open by pressurizing the drug bag from the outside, and the drug bag has a single internal cavity, so the two types of drug solution are mixed and the infusion set is punctured A rubber stopper is punctured with a needle, and a drug solution can be administered from a drug bag. Therefore, in this type of medical mixed-type multi-chamber container, it is essential to mix the two liquids by peeling and opening the weak seal portion prior to the administration of the chemical solution, while the weak seal portion is not opened. When the rubber stopper is punctured at the discharge port, there is a possibility of an erroneous operation in which only the drug solution in the compartment on the discharge port side is administered. As a prior art to cope with this problem, in addition to the first weak seal portion that separates the internal cavity of the drug bag into two compartments, a second weak seal portion is provided immediately before the discharge port, By setting the second second weak seal portion to be equal to or higher than the pressure required for opening the weak seal portion, the first weak seal portion and then the second weak seal portion are opened in this order. Thus, there has been proposed a method in which discharge is performed after mixing of chemicals (see Patent Document 1).
JP-A-9-327498

特許文献1の技術は二つの隔室を分離する第1の弱シール部に加えて排出口の直前に(第1の弱シール部から離間した部位に)第2の弱シール部を設け、これらの弱シール部を順次開通させることで未混合のままの薬液の投与を防止しようとしているが、溶着温度の大小により弱シール部を2個所設けているため、製造工程が複雑化し、コスト増となっていた。また、シール部の溶着強度を第1の弱シール部<第2の弱シール部としていても、シール箇所が薬剤バッグにおける相互に離間した部位にあるため、第1の弱シール部及び第2の弱シール部に対する薬剤バッグ開通時の圧力波の伝達に遅速があり、第1の弱シール部と第2の弱シール部とで必ずしも時系列的に同一値の圧力がかかるとはいえないため、薬剤バッグの加圧の仕方(圧力波の伝達の仕方)によっては第2のシール部に最初に大きな力が加わり、開通してしまい、薬液が排出口に流出するため、薬剤バッグ内の圧力が即座に消失して第1のシール部は未開通のままということがあり得る。この場合、穿刺により投与作業にそのまま移行してしまう可能性があり、未混合で1液のみ投与されてしまう結果となっていた。   In the technique of Patent Document 1, in addition to the first weak seal portion that separates the two compartments, a second weak seal portion is provided immediately before the discharge port (at a position apart from the first weak seal portion). In order to prevent the administration of unmixed chemical solution by sequentially opening the weak seal part, two weak seal parts are provided depending on the welding temperature, which complicates the manufacturing process and increases costs. It was. Further, even if the welding strength of the seal portion is set as the first weak seal portion <the second weak seal portion, the seal portion is located in a portion separated from each other in the drug bag, and thus the first weak seal portion and the second weak seal portion Since there is a slow speed in the transmission of the pressure wave at the time of opening the drug bag to the weak seal portion, it cannot be said that the same pressure is applied in time series in the first weak seal portion and the second weak seal portion. Depending on how the drug bag is pressurized (how the pressure wave is transmitted), a large force is initially applied to the second seal portion and the second seal portion is opened, and the drug solution flows out to the discharge port. It may disappear immediately and the first seal may remain unopened. In this case, there is a possibility of shifting to the administration work as it is due to puncturing, and only one solution is administered without mixing.

この発明は以上の問題点に鑑みてなされてものであり、未開通の状態では投与を行い得ない多液混合型の薬剤バッグの新規な構造を提供し、製造コストが低廉でありかつユーザ側の作業性が良好であるにもかかわらず、誤操作の可能性をより確実に排除することを目的とする。   The present invention has been made in view of the above-mentioned problems, and provides a novel structure of a multi-liquid mixed type drug bag that cannot be administered in an unopened state, is low in manufacturing cost, and is low on the user side. The object is to more surely eliminate the possibility of erroneous operation despite the fact that the workability of the above is good.

この発明になる複室容器は、可撓性フィルムにて形成され、内部空洞をそれぞれの薬液の収納のための複数の隔室に分離するべく薬剤バッグの対向面を加圧剥離可能に溶着して成る溶着部を備えた薬剤バッグと、薬液の排出のため輸液セットにより穿刺される栓体を備えた排出口とを備えた複室容器であって、前記排出口は薬剤バッグの内部空洞側に可撓性連通制御部材を備え、前記可撓性連通制御部材は通常時においては排出口を薬剤バッグの内部空洞に対して実質的に閉鎖せしめる第1の形状をなし、加圧による溶着部の剥離開通時に惹起された内部液圧により可撓性連通制御部材は第1の形状から変形して、排出口を薬剤バッグの内部空洞に対して連通せしめる第2の形状をなす。   The multi-chamber container according to the present invention is formed of a flexible film and welds the opposing surfaces of the drug bag so as to be pressure-separated so as to separate the internal cavity into a plurality of compartments for storing respective chemical solutions. A multi-chamber container including a drug bag having a welded portion and a discharge port provided with a stopper punctured by an infusion set for discharging the drug solution, the discharge port being located on the side of the internal cavity of the drug bag A flexible communication control member, and the flexible communication control member normally has a first shape for substantially closing the discharge port with respect to the internal cavity of the drug bag, and is welded by pressure. The flexible communication control member is deformed from the first shape by the internal hydraulic pressure caused when the peeling is opened, and has a second shape that allows the discharge port to communicate with the internal cavity of the drug bag.

可撓性連通制御部材はゴム製の筒状挿入体等として構成することができ、通常時においては排出口を薬剤バッグの内部空洞に対して実質的に閉鎖せしめる第1の形状(薬剤バッグの内部空洞に向けて偏倚した形状)をなしているため、誤って輸液セットの穿刺針を栓体に穿刺したとしても実質的な液流が得られず、片側の隔室の薬剤のみで輸液作業をしてしまうとういことがない。ここに、実質的に閉鎖とは可撓性連通制御部材の幾分の開口はあっても許容する、という意味であり、幾分の隙間の存在により穿刺により少量の薬液投与は最初は行い得るが、滴下速度に追いつかないため、それ以上の投与は行い得ないため、実際上の問題がなく。また、可撓性連通制御部材を介して少量の薬液が排出口側に漏洩するため製造時の滅菌保証作業が容易となる利点もある。   The flexible communication control member can be configured as a rubber cylindrical insert or the like, and in a normal state, the flexible communication control member has a first shape that substantially closes the discharge port with respect to the internal cavity of the drug bag (the drug bag Therefore, even if the puncture needle of the infusion set is accidentally punctured into the plug body, a substantial liquid flow cannot be obtained, and the infusion work is performed only with the medicine in one compartment. If you do, it will not be ugly. Here, substantially closed means that some opening of the flexible communication control member is allowed, and a small amount of drug solution can be initially administered by puncture due to the presence of some gap. However, since it cannot keep up with the dripping speed, no further administration is possible, so there is no practical problem. Moreover, since a small amount of chemical liquid leaks to the discharge port side via the flexible communication control member, there is an advantage that sterilization guarantee work at the time of manufacture becomes easy.

輸液バッグの加圧により溶着部を隔離開通させる際に薬剤バッグ内部に瞬間的に高まる液圧が生ずるが、この高液圧により可撓性連通制御部材は、その弾性により、排出口を薬剤バッグの内部空洞に対して連通せしめる第2の形状(薬剤バッグの内部空洞から離間側、即ち、栓体側に偏倚した形状)をなすため、輸液セットの穿刺針を栓体に穿刺することにより可撓性連通制御部材も穿刺針により突き破られ、混合薬液を輸液セットに導き、輸液を行うことができる。   When the welded portion is isolated and opened by pressurizing the infusion bag, a fluid pressure that instantaneously increases is generated inside the drug bag. Due to this high fluid pressure, the flexible communication control member makes the discharge port open to the drug bag due to its elasticity. In order to form a second shape that communicates with the internal cavity of the drug bag (a shape that is biased toward the side away from the internal cavity of the drug bag, that is, the plug body), the puncture needle of the infusion set is punctured into the plug body. The sexual communication control member is also broken by the puncture needle, and the mixed drug solution can be guided to the infusion set to perform the infusion.

薬剤排出口に設けられる可撓性連通制御部材を未開通時は実質的に閉鎖させることで、薬剤投与を実質的に阻止する形状とすることで、未開通状態における薬剤の誤投与を防止し、かつ開通時の液圧による可撓性連通制御部材を開口した第2形状に変形させることで、薬剤バッグの開通動作(薬液の混合)を薬剤の投与に連動させることができ、ミスのない効率的な輸液作業を実現することができる。   The flexible communication control member provided at the drug discharge port is substantially closed when not opened, so that the drug administration is substantially blocked, thereby preventing erroneous administration of the drug in an unopened state. In addition, by deforming the flexible communication control member by the fluid pressure at the time of opening into the second shape opened, the opening operation (mixing of the drug solution) of the drug bag can be interlocked with the administration of the drug, and there is no mistake An efficient infusion operation can be realized.

図1から図3において、複室容器は薬液の収納のための平坦状の薬剤バッグ10と、筒状排出口12とから構成される。薬剤バッグ10は厚さ200ミクロンといったポリエチレンフィルムなどの多層構造の合成樹脂軟弱フィルム(本発明の可撓性フィルム)を素材とする。薬剤バッグ10を構成する合成樹脂軟弱フィルムは一対の切片11A, 11Bが筒状排出口12を挟んで重ねられ、全外周部がポリエチレンの場合は130℃といった高温で溶着され、筒状排出口12の部位も含めた全周に沿った強シール部14を形成する。筒状排出口12以外の部位での溶着はポリエチレンフィルム同士であり、筒状排出口12の部位での溶着は筒状排出口12とポリエチレンフィルムとであり、同時には溶着できないので、別工程で溶着(強シール)が実施され、筒状排出口12での強シール部を残余の部位でのそれと区別するため14-1にて示す。強シール部14及び14-1での溶着は薬剤バッグ10の開通ため加圧したときの薬剤バッグ内に生ずる程度の圧力では剥離するようなことはないような温度(ポリエチレンの場合は前述のように130℃程度)で行われ、これにより外部からの物理的な力の影響にかかわらず、薬剤バッグ10内に薬液を漏洩することなく保持することができる。筒状排出口12はその筒形状を維持することができる肉厚(剛性)のプラスチック成形品として構成される。筒状排出口12は図1の下端で薬剤バッグ10から突出しており、薬剤バッグ10の下端から突出する筒状排出口12の下端に、輸液時に輸液セットの穿刺針22により穿刺されるゴム栓20(栓体)が装着されている。   1 to 3, the multi-chamber container includes a flat drug bag 10 for storing a chemical solution and a cylindrical discharge port 12. The drug bag 10 is made of a synthetic resin soft film (flexible film of the present invention) having a multilayer structure such as a polyethylene film having a thickness of 200 microns. The synthetic resin soft film constituting the drug bag 10 has a pair of sections 11A and 11B stacked with the cylindrical discharge port 12 sandwiched therebetween. When the entire outer peripheral portion is made of polyethylene, it is welded at a high temperature of 130 ° C. The strong seal portion 14 is formed along the entire circumference including the region. Welding at parts other than the cylindrical outlet 12 is between polyethylene films, and welding at the part of the cylindrical outlet 12 is between the cylindrical outlet 12 and the polyethylene film, and cannot be welded at the same time. Welding (strong sealing) is performed, and the strong sealing portion at the cylindrical discharge port 12 is indicated by 14-1 to distinguish it from that at the remaining portion. The welding at the strong seal portions 14 and 14-1 is a temperature at which the pressure does not peel at the pressure generated in the drug bag when the drug bag 10 is pressurized to open the drug bag 10 (as described above in the case of polyethylene). Thus, regardless of the influence of external physical force, the drug solution can be held in the drug bag 10 without leaking. The cylindrical discharge port 12 is configured as a thick (rigid) plastic molded product capable of maintaining the cylindrical shape. The cylindrical discharge port 12 protrudes from the drug bag 10 at the lower end of FIG. 1, and a rubber stopper that is punctured by the puncture needle 22 of the infusion set at the lower end of the cylindrical discharge port 12 protruding from the lower end of the drug bag 10 20 (plug) is attached.

薬剤バッグ10を構成する2枚の合成樹脂フィルム切片11A, 11Bは薬剤バッグ10の長手方向(図1の上下方向)の中間部位で全幅にて加圧剥離可能に溶着され、弱シール部(溶着部)24を構成する。弱シール部24によって薬剤バッグ10の内部空洞は図1の上下における第1及び第2の隔室26, 28に分離され、第1及び第2の隔室26, 28に夫々第1及び第2の薬液を分離状態で収納することができる。弱シール部24における、薬剤バッグ10を構成する図1の左右の合成樹脂フィルム切片11A, 11Bの溶着は加圧剥離可能である。加圧剥離可能とは、薬剤バッグ10の開通のため薬剤バッグ10を手のひらなどで適当な力で加圧したとき、薬剤バッグ10内に生ずる液体圧力で弱シール部24において合成樹脂フィルム切片11A, 11Bが剥離されることを意味し、この発明の実施形態におけるポリエチレン樹脂の場合は弱シール部24での溶着は120℃(強シール部14を得るための前記した130℃といった溶着温度より相当低い溶着温度)といった温度にて行われる。弱シール部24の開通による合成樹脂フィルム切片11A, 11Bの剥離状態が図4に示されている。   The two synthetic resin film sections 11A and 11B constituting the drug bag 10 are welded so as to be able to be peeled by pressure at the entire width in the longitudinal direction (vertical direction in FIG. 1) of the drug bag 10, and weakly sealed (weld) Part) 24. The inner cavity of the medicine bag 10 is separated into the first and second compartments 26 and 28 in the upper and lower parts of FIG. 1 by the weak seal portion 24, and the first and second compartments 26 and 28 are separated into the first and second compartments, respectively. Can be stored in a separated state. The welding of the left and right synthetic resin film sections 11A and 11B of FIG. 1 constituting the drug bag 10 in the weak seal portion 24 can be performed by pressure separation. The pressure peelable means that when the drug bag 10 is pressed with an appropriate force with a palm or the like for opening the drug bag 10, the synthetic resin film section 11A, 11B is peeled off, and in the case of the polyethylene resin according to the embodiment of the present invention, the welding at the weak seal portion 24 is 120 ° C. (which is considerably lower than the above-described welding temperature such as 130 ° C. for obtaining the strong seal portion 14). The welding temperature). FIG. 4 shows the peeled state of the synthetic resin film sections 11A and 11B due to the opening of the weak seal portion 24.

排出口12の内部にゴム製筒状挿入体30(この発明の可撓性連通制御部材)が配置されている。ゴム製筒状挿入体30は筒状をなし、適当な肉厚のゴム素材、例えば、エラストマーゴムなどによって形成され、外周縁30-1が排出口12の内周に溶着などにより接合されている。図1に示すように、この接合縁30-1から挿入体30の延長部分は内側に折り返され、この折り返し部分30-2は薬剤バッグ10の空洞部に向けて先細の形状をなし、先端部は切れ目(合せ目)30-3となっているが、 この合せ目30-3の部位で挿入体30を構成するゴム素材面は密着しているため、薬液は挿入体30を実質的に流通し得ないようになっている。しかしながら、この密着状態は薬液の少量の流通は許容する程度でも良く、ゴムの素材や肉厚を適切に選定することで、最適な密閉度を得ることが可能である。挿入体30は、その弾性により、図1に示すように中央部が薬剤バッグ10の内部空洞側(ゴム栓20から離間側)に大きく湾曲突出した第1の形状(状態)と図4に示すようにゴム栓20の側(薬剤バッグ10の内部空洞から離間側)に変形した第2の形状(状態)との2個の安定形状(状態)との間で変位可能となる。このような2位置(形状)の安定を得るため、ゴムの材質や肉厚や成形型内での加硫条件等の諸因子の適切な設定が必要なことはいうまでもない。   A rubber cylindrical insert 30 (a flexible communication control member of the present invention) is disposed inside the discharge port 12. The rubber cylindrical insert 30 has a cylindrical shape, is formed of a rubber material having an appropriate thickness, for example, elastomer rubber, and the outer peripheral edge 30-1 is joined to the inner periphery of the discharge port 12 by welding or the like. . As shown in FIG. 1, the extended portion of the insert 30 is folded inward from the joint edge 30-1, and the folded portion 30-2 has a tapered shape toward the hollow portion of the medicine bag 10. Has a cut (joint) 30-3, but since the rubber material surface constituting the insert 30 is in close contact with the portion of the joint 30-3, the chemical solution substantially circulates through the insert 30. It is not possible. However, this close contact state may be such that a small amount of chemical solution can be allowed to flow, and an optimal sealing degree can be obtained by appropriately selecting a rubber material and a wall thickness. As shown in FIG. 1, the insertion body 30 has a first shape (state) in which the central portion is greatly curved and protrudes toward the inner cavity side (the side away from the rubber plug 20) of the drug bag 10 as shown in FIG. Thus, it is possible to displace between the two stable shapes (states) and the second shape (state) deformed to the rubber plug 20 side (the side away from the internal cavity of the drug bag 10). Needless to say, in order to obtain stability at these two positions (shapes), it is necessary to appropriately set various factors such as the material and thickness of the rubber and the vulcanization conditions in the mold.

弱シール部24により隔室26, 28が分離された薬剤バッグの未開通時においてはゴム製挿入体30は図1に示すようにその中央部が隔室26に向けて突出した第1状態にある。この場合、輸液セットの穿刺針22によりゴム栓20を2点鎖線22´のように刺入しても、挿入体30は実質的に閉鎖状態にあり、挿入体30を介しての液流は阻止され、又は、合せ目30-3の部位を介して少量の液流があっても滴下速度に達し得ない程の少量であるため、実質的に薬剤の投与は行い得ず、隔室26内の薬液のみが輸液されてしまうという誤作業(未開通状態のままでの輸液作業)を防止することができる。   When the medicine bag in which the compartments 26 and 28 are separated by the weak seal portion 24 is not opened, the rubber insert 30 is in the first state in which the central portion projects toward the compartment 26 as shown in FIG. is there. In this case, even if the rubber stopper 20 is inserted by the puncture needle 22 of the infusion set as indicated by a two-dot chain line 22 ', the insert 30 is substantially closed, and the liquid flow through the insert 30 is Since the amount is so small that the drop rate cannot be reached even if a small amount of liquid flow is made through the portion of the seam 30-3, the administration of the drug cannot be performed substantially. It is possible to prevent an erroneous operation (an infusion operation in an unopened state) in which only the drug solution is infused.

弱シール部24の開通は、薬剤バッグ10を机などの上に平坦に載置し、薬剤バッグ10を手のひらで加圧することにより行われる。即ち、加圧により加わる薬液の圧力により弱シール部24において薬剤バッグ10の両層が分離(弱シール部24が分離した状態を図4に示す)し、隔室26, 28は一体となり、それまで隔室26, 28に分離収容されていた薬液は混合される。そして、弱シール部24の開通の瞬間に生じた薬液の圧力は図1の矢印fのように挿入体30の全面に衝撃的に作用し、図1において薬剤バッグ10の内部空洞に向けていた延長部分30-2は、図4に示すように、排出口12の内面に沿接するように反転位置され、先端の合せ目30-3は大きく分離され、開口32を形成する。この第2状態(形状)においては挿入体30は開口部32を呈しているため、穿刺針を22´に示すようにゴム栓20に穿刺した場合に、薬剤バッグ10内の混合薬液を開口部32を介して輸液セットに取り出すことができる。   The weak seal portion 24 is opened by placing the drug bag 10 flat on a desk or the like and pressurizing the drug bag 10 with the palm of the hand. That is, both layers of the drug bag 10 are separated at the weak seal portion 24 by the pressure of the chemical liquid applied by pressurization (the state where the weak seal portion 24 is separated is shown in FIG. 4), and the compartments 26 and 28 are integrated. The chemicals separated and accommodated in the compartments 26 and 28 are mixed. And the pressure of the chemical | medical solution produced at the moment of opening of the weak seal | sticker part 24 acts on the whole surface of the insertion body 30 like the arrow f of FIG. 1, and was aiming at the internal cavity of the chemical | medical agent bag 10 in FIG. As shown in FIG. 4, the extended portion 30-2 is inverted so as to be in contact with the inner surface of the discharge port 12, and the tip joint 30-3 is largely separated to form an opening 32. In this second state (shape), since the insert 30 has the opening 32, when the rubber stopper 20 is punctured with the puncture needle 22 ', the mixed drug solution in the drug bag 10 is opened. 32 can be taken out into the infusion set.

前述のようにゴム製挿入体30の閉塞状態(図1)は必ずしも100%の密封である必要はない。合せ目30-3を介して幾分の漏洩を許容することにより、排出口12に薬液がある状態で製品の滅菌を行うことができ、滅菌保証を得やすくなる。また、薬液は排出口12の側に幾分漏洩するため、弱シール部24が未開通の状態での輸液セットの穿刺針を想像線22´のように穿刺することにより幾分の薬液の投与はされ得るが、滴下速度に追い付けないため、それ以上の投与は継続できないため、未開通で穿刺しても誤作業にはつながらない。   As described above, the closed state (FIG. 1) of the rubber insert 30 does not necessarily need to be 100% sealed. By allowing some leakage through the seam 30-3, the product can be sterilized in the state where there is a chemical solution at the discharge port 12, and sterilization guarantee can be easily obtained. Further, since the drug solution leaks somewhat to the side of the discharge port 12, administration of some drug solution is performed by puncturing the puncture needle of the infusion set with the weak seal portion 24 unopened as indicated by the imaginary line 22 '. However, since it is not possible to keep up with the dropping speed, further administration cannot be continued, so that puncture without opening does not lead to erroneous work.

ゴム製挿入体30の装着の作業効率を高めるため、図5に示すように、筒状挿入体30の外側に筒状のプラスチックキャップ40を設けた組立体として構成するようにしても良い。キャップ40は排出口12と同一素材(ポリエチレン)にて形成される。このようにして構成された組立体は排出口12に簡便に挿入(圧入)され、プラスチックキャップ40と排出口12とを溶着する構造とすることができる。   In order to improve the work efficiency of mounting the rubber insert 30, as shown in FIG. 5, it may be configured as an assembly in which a cylindrical plastic cap 40 is provided outside the cylindrical insert 30. The cap 40 is formed of the same material (polyethylene) as the discharge port 12. The assembly configured as described above can be simply inserted (press-fitted) into the discharge port 12 to weld the plastic cap 40 and the discharge port 12.

図1はこの発明の複室型容器の部分的断面図であり、未開通状態を示す。FIG. 1 is a partial cross-sectional view of the multi-chamber container of the present invention, showing an unopened state. 図2はこの発明の複室型容器の部分的平面図を示す。FIG. 2 shows a partial plan view of the multi-chamber container of the present invention. 図3は図1のIII−III線に沿った矢視図(ゴム製筒状挿入体30のみ示す)である。3 is a view taken along the line III-III in FIG. 1 (only the rubber cylindrical insert 30 is shown). 図4は図1の複室型容器の開通状態を示す。FIG. 4 shows the open state of the multi-chamber container of FIG. 図5はゴム製筒状挿入体の装着方法の別実施例を示す部分図である。FIG. 5 is a partial view showing another embodiment of the mounting method of the rubber cylindrical insert.

符号の説明Explanation of symbols

10…薬剤バッグ
12…排出口
14…強シール部
20…ゴム栓
22…穿刺針
24…弱シール部
26, 28…隔室
30…ゴム製筒状挿入体






DESCRIPTION OF SYMBOLS 10 ... Drug bag 12 ... Outlet 14 ... Strong seal part 20 ... Rubber stopper 22 ... Puncture needle 24 ... Weak seal part
26, 28 ... compartment 30 ... rubber cylindrical insert






Claims (4)

可撓性フィルムにて形成され、内部空洞をそれぞれの薬液の収納のための複数の隔室に分離するべく薬剤バッグの対向面を加圧剥離可能に溶着して成る溶着部を備えた薬剤バッグと、薬液の排出口とを備えた複室容器であって、前記排出口は薬剤バッグの内部空洞に対する開閉のための可撓性連通制御部材を備え、前記可撓性連通制御部材は通常時においては前記排出口を薬剤バッグの内部空洞に対して実質的に閉鎖せしめる第1の形状をなし、加圧による溶着部の剥離開通時に惹起された内部液圧により可撓性連通制御部材は前記第1の形状から変形し、排出口を薬剤バッグの内部空洞に対して連通せしめる第2の形状をなす複室容器。   A drug bag comprising a welded portion formed of a flexible film and formed by welding the opposite surfaces of the drug bag so as to be capable of being pressure-separated so as to separate the internal cavity into a plurality of compartments for storing respective drug solutions. And a multi-chamber container having a chemical solution discharge port, wherein the discharge port includes a flexible communication control member for opening and closing the internal cavity of the drug bag, and the flexible communication control member is normally used. In the first embodiment, the discharge port is substantially closed with respect to the internal cavity of the drug bag, and the flexible communication control member is formed by the internal fluid pressure caused when the welded portion is peeled and opened by pressurization. A multi-chamber container having a second shape which is deformed from the first shape and allows the discharge port to communicate with the internal cavity of the drug bag. 請求項1に記載の発明において、前記可撓性連通制御部材は弾性素材にて形成された筒状挿入体として形成された複室容器。   2. The multi-chamber container according to claim 1, wherein the flexible communication control member is formed as a cylindrical insert formed of an elastic material. 請求項2に記載の発明において、筒状挿入体の外周に排出口と同一系統のプラスチック系素材にて形成された外周筒状部材が設けられて筒状挿入体とで組立体を構成し、この組立体が排出口に装着された複室容器。   In the invention according to claim 2, an outer peripheral cylindrical member formed of a plastic material of the same system as the discharge port is provided on the outer periphery of the cylindrical insert, and an assembly is configured with the cylindrical insert. A multi-chamber container in which this assembly is attached to the discharge port. 可撓性フィルムにて形成され、内部空洞をそれぞれの薬液の収納のための複数の隔室に分離するべく薬剤バッグの対向面を加圧剥離可能に溶着して成る溶着部を備えた薬剤バッグと、薬液の排出のため輸液セットの穿刺針により穿刺される栓体を備えた排出口とを備え、前記排出口は薬剤バッグの内部空洞に対する開閉のための可撓性連通制御部材を備えた複室容器を準備し、前記可撓性連通制御部材を未開通時においては前記排出口を薬剤バッグの内部空洞に対して実質的に閉鎖せしめる第1の形状を呈せしめることにより輸液セットの穿刺針による栓体の穿刺に係わらず、輸液を阻止するようにし、輸液開始時に溶着部を加圧により剥離開通させると共に、加圧による溶着部の剥離開通時に惹起された内部液圧により可撓性連通制御部材は第1の形状から変形して、排出口を薬剤バッグの内部空洞に対して連通せしめる第2の形状となして、栓体をして輸液セットの穿刺針により穿刺せしめることにより輸液作業を開始するようにした輸液方法。






A drug bag comprising a welded portion formed of a flexible film and formed by welding the opposite surfaces of the drug bag so as to be capable of being pressure-separated so as to separate the internal cavity into a plurality of compartments for storing respective drug solutions. And a discharge port provided with a plug punctured by a puncture needle of an infusion set for discharging the drug solution, the discharge port including a flexible communication control member for opening and closing the internal cavity of the drug bag Puncturing the infusion set by preparing a multi-chamber container and presenting a first shape that substantially closes the outlet to the internal cavity of the drug bag when the flexible communication control member is not opened Regardless of the puncture of the plug body with the needle, the infusion is blocked, the welded part is peeled open by pressurization at the start of the infusion, and the internal fluid pressure caused by the pressurization of the welded part is flexible Communication control member The infusion operation is started by deforming from the first shape to form a second shape in which the discharge port communicates with the internal cavity of the drug bag, and punctures with the puncture needle of the infusion set after plugging. Infusion method.






JP2006239716A 2006-09-05 2006-09-05 Multi-chamber container Pending JP2008061669A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006239716A JP2008061669A (en) 2006-09-05 2006-09-05 Multi-chamber container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006239716A JP2008061669A (en) 2006-09-05 2006-09-05 Multi-chamber container

Publications (1)

Publication Number Publication Date
JP2008061669A true JP2008061669A (en) 2008-03-21

Family

ID=39284913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006239716A Pending JP2008061669A (en) 2006-09-05 2006-09-05 Multi-chamber container

Country Status (1)

Country Link
JP (1) JP2008061669A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009285457A (en) * 2008-04-30 2009-12-10 Torque Seimitsu Kogyo Kk Infusion bag and port
JP2013006060A (en) * 2007-07-17 2013-01-10 Ajinomoto Co Inc Multi-chamber container
JP2017060542A (en) * 2015-09-24 2017-03-30 株式会社大協精工 Stopper with port

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003305107A (en) * 2002-02-14 2003-10-28 Otsuka Pharmaceut Factory Inc Medicine discharge member and medical double-chamber container
JP2004248892A (en) * 2003-02-20 2004-09-09 Terumo Corp Medical container
JP2005028041A (en) * 2003-07-11 2005-02-03 Medicalseed:Kk Sealing plug for partition bag

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003305107A (en) * 2002-02-14 2003-10-28 Otsuka Pharmaceut Factory Inc Medicine discharge member and medical double-chamber container
JP2004248892A (en) * 2003-02-20 2004-09-09 Terumo Corp Medical container
JP2005028041A (en) * 2003-07-11 2005-02-03 Medicalseed:Kk Sealing plug for partition bag

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013006060A (en) * 2007-07-17 2013-01-10 Ajinomoto Co Inc Multi-chamber container
JP2009285457A (en) * 2008-04-30 2009-12-10 Torque Seimitsu Kogyo Kk Infusion bag and port
JP2017060542A (en) * 2015-09-24 2017-03-30 株式会社大協精工 Stopper with port

Similar Documents

Publication Publication Date Title
JP4993220B2 (en) Multi-chamber container
JP4930772B2 (en) Communicating needle used to communicate two or more containers
WO2004047714A1 (en) Multiple-chamber medical container and method for producing the same
JP5057172B2 (en) Multi-chamber container
JP4854940B2 (en) Medical multi-chamber container
JP2008061669A (en) Multi-chamber container
JP2007190161A (en) Double-chamber container
JP4481708B2 (en) Medical multi-chamber container
JP4366131B2 (en) Multi-chamber container
JP4962733B2 (en) Multi-chamber container
JP2007260252A (en) Medical container
JP5491814B2 (en) Multi-chamber container
JP2011131104A (en) Medical double-chamber container
JP4599918B2 (en) Drug storage sealing body and method for forming drug storage sealing body
JP2009018038A (en) Multi-chambered container
JP2007185418A (en) Multi-chamber container
JP2008200367A (en) Medical container
JP2009154024A (en) Double-chamber container
WO2016152981A1 (en) Medical bag
JP2000262589A (en) Double chamber container
JP2008036336A (en) Dual chamber container
JP4821971B2 (en) Drug storage sealing body and adhesive seal
JP5024526B2 (en) Multi-chamber container
JP4365948B2 (en) Infusion bag
JP5223244B2 (en) Multi-chamber container

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090522

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110216

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110323

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110603